SSI Diagnostica A/S: Financial statements 2024
CVR: 37294535
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
SSI Diagnostica A/S (CVR 37294535) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 238,337,916 and a net result of DKK -57,738,206 compared with DKK -126,826,368 the year before. That is an increase of 17.5% compared with the year before. The profit margin was -24.2%. Equity in the 2024 report amounted to DKK 1,270,027,584. The solvency ratio was 47.5%. The company had 121 employees in the financial year.
- Revenue
- DKK 238,337,916
- Gross Profit
- DKK 121,453,148
- Profit/Loss
- DKK -57,738,206
- Equity
- DKK 1,270,027,584
- Total Assets
- DKK 2,672,996,881
- Employees
- 121
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 238.3M | 121.5M | -57.7M | 1.3B | 121 |
| 2023 | 202.8M | 107.4M | -126.8M | 1.2B | 112 |
| 2022 | 316.1M | 115.7M | 38.1M | 1B | 125 |
| 2021 | - | 274.5M | 251.4M | 690.1M | 113 |
| 2020 | - | 170.2M | 80M | 394.9M | 112 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
SSI Diagnostica A/S has won the tender "Levering, installation og validering af nyt udstyr og reagenser til bakteriologisk automatisering på Hvidovre Hospital via en totalentreprise der også indeholder bygningsmæssige ændringer." issued by Region Hovedstaden worth 59,500,000 DKK.
As of July 31, 2024, Egil Mølsted Madsen has stepped down as director of SSI Diagnostica A/S.
SSI Diagnostica A/S has published its annual report for 2023. Revenue came to DKK 202,775,841, and the net result was DKK -126,826,368.
As of June 26, 2024, Egil Mølsted Madsen has joined the board of directors of SSI Diagnostica A/S.
SSI Diagnostica A/S has won the tender "Anskaffelse af WASP modul" issued by Region Midtjylland worth 4,800,000 DKK.
About SSI Diagnostica A/S
SSI Diagnostica A/S is a Danish company of the type Aktieselskab based in Hillerød, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Christina Charlotte Lindved and Lars Henrik Vejrup Hansen. The board consists of Nachum Shamir (chair), Ingo Sujit Michael Chakravarty, Joseph Edward Bernardo and Patrik Olof Dahlén. The company is owned by SSI Diagnostica Holding A/S. The company has 151 employees (2026). In 2025, the company reported revenue of DKK 320,248,428 and a net result of DKK -107,420,232 compared with DKK -57,738,206 the year before. Equity in the 2025 report amounted to DKK 695,791,068.
